Cannabis Law Report

JULY 27, 2021

The longitudinal study showed that individuals who used artisanal cannabidiol (CBD) products reported better quality of life, lower psychiatric symptom severity and fewer medication-related adverse events compared with those not using CBD. This study represents a refreshing collaboration of scientists, clinicians, patients and advocates.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. (E-commerce sales of CBD in the U.S. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

LifeCannMD

MAY 27, 2025

” I completely understand this concern, and that’s exactly why I’m passionate about educating patients about microdosing cannabis. Now, with 1.5mg of a balanced THC:CBD tincture twice daily, he’s giving presentations at work and actually enjoying social events again.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JUNE 4, 2021

Clinical trial information: NCT03276572 ( [link] ). The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law. Abstract Number: 5015. Date and Time: Available Starting June 4, 2021 , 9:00 am (EST).

Data 100

Data Research and Development Clinical Trials Therapy 100

TheAnswerPage

JANUARY 11, 2022

As the Editor-in-Chief of the medical education website called TheAnswerPage.com for nearly two decades, I have assessed multiple educational gaps in the healthcare community. Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop?

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

AUGUST 3, 2021

For CUNY, the Contract operationalizes the CDC’s ‘ Guidance for Institutions of Higher Education ’ aimed at disease control and minimizing the risk of exposure in education settings. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.

Clinical Trials 81

Clinical Trials Therapy Collective Research and Development 81

Cannabis Law Report

JULY 28, 2021

We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JANUARY 27, 2022

Based on cohorts of children with special educational needs, the prevalence of fragile X syndrome (FXS) is estimated to be 1 in 4,000 in males, and 1 in 8,000 in females. The majority of industry-sponsored drugs in active clinical development for FXS are in Phase II, with two drugs in Phase III. RECENT EVENTS AND ANALYST OPINION.

Clinical Trials 40

Clinical Trials Therapy Cannabinoids Topical 40

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. POPLAR is the first academic initiative focused on psychedelics law and policy, positioned to be a global leader for research and education in this space. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

SEPTEMBER 2, 2021

Suffolk County Community College joins new safeCircle client The City University of New York, as well as several existing higher education institution clients, who have turned to us for COVID-19 testing to support their 2021-2022 academic year,” stated Dr. James A. Hayward, president and CEO of Applied DNA. “As

Clinical Trials 76

Clinical Trials Research and Development Therapy Collective 76

SpeedWeed

AUGUST 16, 2021

and industry-leading Cannabis Business Times, Cannabis Dispensary, and Hemp Grower magazines, announces today President of Scottsdale Research Institute (SRI) Sue Sisley, MD, as the keynote speaker on Day 2 of its annual event, to take place Aug. 24-26, 2021, at Paris Las Vegas Hotel & Casino. 25 from 11 a.m. – 24-26, 2021.

Media 52

Media Clinical Trials DEA Hemp 52

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

Cannabis Law Report

OCTOBER 17, 2019

The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

JANUARY 12, 2022

As Oregon prepares to roll out the nation’s first legal psilocybin-assisted services program, there is a recognized need for the community to track adverse events and measure efficacy. This level of understanding can inform best practices, improve outcomes, and contribute to sensible policy-making both in Oregon and beyond.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

JULY 6, 2021

The US Food and Drug Administration is also currently sponsoring clinical trials that could lead to the federal legalization of psilocybin- and MDMA -assisted therapy within the next two years. The project also intends to advance research into how psychedelics can heal trauma and how to ensure equitable access to these therapies.

Policy 52

Policy Law Research and Development Therapy 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. . How Do CBD Drug Interactions Occur?

CBD 98

CBD THC Conditions Medicine 98

MMJ Recs

JULY 11, 2024

It is often caused by life events such as stress, anxiety, or a significant change in routine. However, more robust clinical trials are needed to validate these findings and determine the optimal dosages and treatment regimens for each disorder. Acute insomnia usually lasts for a few days to a few weeks.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

MARCH 29, 2020

At an HIV Community Cannabis Education event held in Toronto, a cannabis company proudly declared their company had not had a single product recall to date. This post explores the manufacturing and research standards to consider when conducting research studies with cannabis. . . Product Quality in Manufacturing.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer. www.imperial.ac.uk.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Cannabis Law Report

OCTOBER 12, 2021

safeCircle’s approach to COVID-19 testing, the combination of a comprehensive managed services offering and self-service reporting and communications platform provided by our partner, CLEARED4, continues to resonate with institutes of higher education seeking to keep populations safe and campuses open. Food and Drug Administration (U.S.

Programs 40

Programs Clinical Trials Research and Development Therapy 40

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. Event details below: Date: Tuesday, September 17th 2019. Time: 9:00AM to 5:00PM.

Programs 40

Programs Research and Development Education Treatment 40

The Cannigma

DECEMBER 22, 2021

I think anyone that gets into this business is, we get addicted to this, to the smart event where we’re working around the clock, there’s always something new. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

Research and Development 98

Research and Development Oil Cannabis Clinical Trials 98

Cannabis Law Report

NOVEMBER 7, 2019

With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient. Cannatrek is actively working on clinical trial protocols with a dedicated focus on mental health.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

SEPTEMBER 20, 2021

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Transaction Highlights.

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

FEBRUARY 28, 2020

The combination of experience, wisdom and the optimism of the recent entrants is positively intoxicating, and has created an exciting buzz at events, but there will be bumps along the road and we should expect teething problems. Events were full of people talking about how this technology would revolutionise everything.

Law 59

Law Research and Development Recreational Cannabis 59

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. [7]. How Do CBD Drug Interactions Occur?

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

DECEMBER 21, 2021

This service is available to businesses, K-12 schools, universities, event venues, medical offices, hospitality groups, and more to facilitate the safe return of people to in-person environments. The IHG Education Foundation supports scholarships for students, removing the barriers to pursuing a career in healthcare.

Research and Development 40

Research and Development Supply Chain Data Business 40

Cannabis Law Report

NOVEMBER 24, 2021

The issue of doctor-patient education was included in the framing codes. Articles framing the need for doctors to be educated about medicinal cannabis occurred in 11 articles, with four articles framing the need for patient education. 23), followed by adverse events ( n ?=?15) 2020 ), stigmatisation (St Pierre et al.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MAY 7, 2021

Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization.

Supply Chain 126

Supply Chain Patients Access Hemp 126

Veriheal

JUNE 7, 2021

While this article has been written for educational purposes, it is important to remember that this substance is listed as a Schedule 1 narcotic in the US. MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . Consuming Therapeutically and Recreationally.

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

SMPL

MAY 26, 2020

We were talking about, ‘What can we do with this?’ ” recalled Samantha Miller, who hosted the event at her split-level house, wedged between redwoods and a creek below. In addition to convincing marijuana dispensaries to widely carry CBD, they wanted to educate the public about its promising benefits. San Francisco weekly.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Thus far, however, there have been no FDA -sanctioned clinical trials to ascertain the efficacy of whole plant, CBD -rich cannabis oil for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials. California. The new law went into immediate effect upon the governor’s signature on October 12, 2019.

Legislation 45

Legislation Patients Access Banking 45

Cannabis Law Report

JUNE 4, 2021

Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51